Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OSU6162 in Bipolar Depression: An Open-label, Flexible Dose Study (OBID)

NCT05296356 is registered in ClinicalTrials.gov with Göteborg University as lead sponsor.

NCT NCT05296356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05296356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OSU6162 in Bipolar Depression: An Open-label, Flexible Dose Study (OBID)
Lead sponsor
Göteborg University
Phase
Phase 2
Overall status
Recruiting
Start date
October 25, 2021
Completion date
May 31, 2029
Enrollment
22 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression